Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: SACHI BIOWORKS, INC.
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2022-04-14 to 2024-04-13
Current total value of award: $1599984
Description: E014042 SBIR PHASE II  REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS